2Martin M J, Hulley SB, Browner WS, et al. Serum cholesterol, blood pressure,and mortality:implications from a cohort of 316,662 men. Lancet, 1986, 11:933.
3The Scandinavian Simavastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian survival study(4s), Lancet, 1994,344:1383.
4Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation,2000, 101:207-213.
5Cleeman JI. Executive summary of the third report of the mational cholesterol education program(NCEP)export panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel III).JAMA,2001,285:2486-2497.
6O'Driscoll G,Green D,Taylor RR. Simvastatin, an HMG-coenzyme a reductase inhibitor, improves endothelial function within 1 month. Circulation, 1997,95:1126-1131.
7Huggins GS, Pastemak RC, Alpert NM, et al. Effects of short-trem treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve.Circulation.1998,98:1291-1296.
8Dupuis J, Tardif JC, Cemacek P, et al. Cholesterol reduction rapidly improves endothelial function after acute conroary syndromes:the RECIFE (Reduction of cholesterol in Ischemia and Function of endothelium ) Trial. Circulation,1999,99:3227-3333.
9Bustos C, Hemandez-Presa MA,Ortego M,et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.J Am Coll Cardiol, 1998,32:2057-2064.
10Ridker PM, Rifai N, Pfeffer MA, et al. For the cholesterol and recurrent events(CARE) investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999,100:230-235.
2Karalis DG,Ross AM,Vacari RM,et al.Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease.Am J Cardiol,2002,89:667-671.
3Schwartz GG,Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent isehemic events in acute coronary syndromes:the MIRACL study : a randomized controlled tria[J]. JAMA ,2001,285 : 1711 -1718.
4Kultuvsay H, Payzin S ,Turkoglu C, et al, Early use of pravastatin in patienta with acute myocardial infarction undergoing coronary angioplasty[J]. Acta Carkiol,2002,57 (4) :295-302.
5Kayikcioglu M,Can L,Evrengul H ,et al. The effect of statin therapy on ventricular late potentials in acute myocardial infarcfion[J]. Int J Cardiol,2003,90( 1 ) :63 -72.
